Clinical trial
Evaluating the Safety and Effectiveness of the Omnipod Horizon™ Automated Glucose Control System in Children With Type 1 Diabetes Aged 2.0-5.9 Years: Preschool Cohort
NCT04476472 is registered in ClinicalTrials.gov with Insulet Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Safety and Effectiveness of the Omnipod Horizon™ Automated Glucose Control System in Children With Type 1 Diabetes Aged 2.0-5.9 Years: Preschool Cohort
- Lead sponsor
- Insulet Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 8, 2020
- Completion date
- October 12, 2022
- Enrollment
- 80 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
type 1 diabetes mellitus